Abstract:Background: The ansamycin class of antibiotics are produced by various Actinomycetes. Their carbon framework arises from the polyketide pathway via a polyketide synthase (PKS) that uses an unusual starter unit. Rifamycin (rif), produced by Amycolatopsis mediterranei, is the archetype ansamycin and it is medically important. Although its basic precursors (3-amino-5-hydroxy benzoic acid AHBA, and acetic and propionic acids) had been established, and several biosynthetic intermediates had been identified, very little was known about the origin of AHBA nor had the PKS and the various genes and enzymes that modify the initial intermediate been characterized. Results: A set of 34 genes clustered around the rifK gene encoding AHBA synthase were defined by sequencing all but 5 kilobases (kb) of a 95 kb contiguous region of DNA from A. mediterranei. The involvement of some of the genes in the biosynthesis of rifamycin B was examined. At least five genes were shown to be essential for the synthesis of AHBA, five genes were determined to encode the modular type I PKS that uses AHBA as the starter unit, and 20 or more genes appear to govern modification of the polyketide-derived framework, and rifamycin resistance and export. Putative regulatory genes were also identified. Disruption of the PKS genes at the end of rifA abolished rifamycin B production and resulted in the formation of P8/1-OG, a known shunt product of rifamycin biosynthesis, whereas disruption of the orf6 and orf9 genes, which may encode deoxysugar biosynthesis enzymes, had no apparent effect. Conclusions: Rifamycin production in A. mediterranei is governed by a single gene cluster consisting of structural, resistance and export, and regulatory genes. The genes characterized here could be modified to produce novel forms of the rifamycins that may be effective against rifamycin-resistant microorganisms.

Rifamycin Biosynthetic Congeners: Isolation and Total Synthesis of Rifsaliniketal and Total Synthesis of Salinisporamycin and Saliniketals A and B

Total Synthesis of Marine Cyclic Enol-Phosphotriester Salinipostin Compounds

Total Synthesis of Amphidinolide Y by Formation of Trisubstituted (E)-Double Bond Via Ring-Closing Metathesis of Densely Functionalized Alkenes.

Synthesis of the C1–C12 Acid Fragment of Amphidinolide T Marine Macrolides Via SmI2-mediated Enantioselective Reductive Coupling of Aldehydes with a Chiral Crotonate

Enantioselective Total Synthesis of the Marine Macrolides Salarins A and C

Total Synthesis of (−)-Platensimycin, a Novel Antibacterial Agent

Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699

8-Deoxy-Rifamycin Derivatives From Amycolatopsis Mediterranei S699 Delta Rift Strain

Total synthesis of structurally diverse pleuromutilin antibiotics

Total Synthesis of Tosyl‐Samroiyotmycin A and Its Biological Profiling

Design and synthesis of a simplified analogue of salacinol

Total synthesis of the salicylate enamide macrolide oximidine II.

Amphidinolides F and C2: An Odyssey in Total Synthesis

Advances Toward Amphidinolides C, F and U: Isolations, Synthetic Studies and Total Syntheses

Evolution of the Short Enantioselective Total Synthesis of the Unique Marine Myxobacteria Polyketide Salimabromide

Isolation of 11,12- seco-Rifamycin W Derivatives Reveals a Cleavage Pattern of the Rifamycin Ansa Chain

Investigations into the Biosynthesis of Salinosporamide A : New Insights on PKS Extender Units and the Origin of a Nonproteinogenic Amino Acid

Deciphering the Timing of Naphthalenic Ring Formation in the Biosynthesis of 8-Deoxyrifamycins

Total Synthesis of Sinensilactam A

Total Synthesis of Complex Peptidyl Nucleoside Antibiotics: Asymmetric De Novo Syntheses of Miharamycin B and Its Biosynthetic Precursor

Asymmetric Synthesis of Phthalascidin, Zalypsis and Renieramycin T from N-Cbz-L-tyrosine